| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 13 | 2023 | 104 | 2.470 |
Why?
|
| Ankyloglossia | 2 | 2020 | 2 | 1.440 |
Why?
|
| Lingual Frenum | 7 | 2020 | 8 | 1.360 |
Why?
|
| Tonsillectomy | 9 | 2020 | 96 | 1.310 |
Why?
|
| Pharyngeal Muscles | 3 | 2013 | 10 | 1.220 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 4 | 2021 | 27 | 1.050 |
Why?
|
| School Admission Criteria | 2 | 2013 | 21 | 0.750 |
Why?
|
| Anti-Dyskinesia Agents | 2 | 2011 | 39 | 0.740 |
Why?
|
| Pain, Postoperative | 6 | 2021 | 255 | 0.730 |
Why?
|
| Laryngeal Neoplasms | 4 | 2010 | 79 | 0.730 |
Why?
|
| Certification | 1 | 2021 | 68 | 0.720 |
Why?
|
| Hemangioma | 4 | 2010 | 94 | 0.710 |
Why?
|
| Botulinum Toxins | 2 | 2011 | 119 | 0.670 |
Why?
|
| Mucormycosis | 1 | 2019 | 26 | 0.640 |
Why?
|
| Induction Chemotherapy | 1 | 2019 | 42 | 0.640 |
Why?
|
| Tongue Diseases | 4 | 2003 | 11 | 0.640 |
Why?
|
| Pediatrics | 4 | 2021 | 1139 | 0.600 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2016 | 9 | 0.560 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 510 | 0.540 |
Why?
|
| Analgesics, Opioid | 4 | 2021 | 401 | 0.540 |
Why?
|
| Adenoidectomy | 7 | 2020 | 74 | 0.530 |
Why?
|
| Developing Countries | 1 | 2016 | 270 | 0.480 |
Why?
|
| Child | 34 | 2023 | 24208 | 0.480 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2008 | 141 | 0.470 |
Why?
|
| Cricoid Cartilage | 2 | 2011 | 16 | 0.470 |
Why?
|
| Internship and Residency | 3 | 2013 | 1158 | 0.460 |
Why?
|
| Pharyngeal Diseases | 1 | 2013 | 17 | 0.450 |
Why?
|
| Infant | 23 | 2022 | 12323 | 0.440 |
Why?
|
| Job Application | 1 | 2013 | 17 | 0.440 |
Why?
|
| Child, Preschool | 23 | 2020 | 13862 | 0.420 |
Why?
|
| Personnel Selection | 1 | 2013 | 63 | 0.420 |
Why?
|
| Airway Obstruction | 3 | 2010 | 163 | 0.400 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 804 | 0.390 |
Why?
|
| Deglutition Disorders | 1 | 2013 | 125 | 0.390 |
Why?
|
| Humans | 70 | 2023 | 123190 | 0.390 |
Why?
|
| Pharynx | 1 | 2011 | 65 | 0.380 |
Why?
|
| Esophageal Achalasia | 1 | 2011 | 35 | 0.360 |
Why?
|
| Neonatal Screening | 4 | 2008 | 184 | 0.340 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2020 | 68 | 0.330 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 216 | 0.330 |
Why?
|
| Male | 45 | 2020 | 60020 | 0.310 |
Why?
|
| Correspondence as Topic | 1 | 2008 | 12 | 0.310 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2003 | 199 | 0.300 |
Why?
|
| Breast Feeding | 2 | 2020 | 220 | 0.300 |
Why?
|
| Dissection | 2 | 2007 | 52 | 0.300 |
Why?
|
| Tympanoplasty | 1 | 2008 | 9 | 0.300 |
Why?
|
| Writing | 1 | 2008 | 59 | 0.290 |
Why?
|
| Speech Disorders | 3 | 2003 | 42 | 0.280 |
Why?
|
| Female | 43 | 2020 | 65427 | 0.280 |
Why?
|
| Endoscopy | 3 | 2019 | 283 | 0.260 |
Why?
|
| Glucocorticoids | 4 | 2017 | 379 | 0.260 |
Why?
|
| Williams Syndrome | 1 | 2006 | 39 | 0.260 |
Why?
|
| Mandibular Neoplasms | 2 | 2017 | 8 | 0.260 |
Why?
|
| Premedication | 1 | 2004 | 43 | 0.240 |
Why?
|
| Otitis Media | 2 | 2002 | 82 | 0.240 |
Why?
|
| Electrocoagulation | 1 | 2004 | 37 | 0.230 |
Why?
|
| Infant, Newborn | 11 | 2020 | 8089 | 0.230 |
Why?
|
| Cold Temperature | 1 | 2004 | 81 | 0.230 |
Why?
|
| United States | 8 | 2023 | 10618 | 0.220 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 246 | 0.220 |
Why?
|
| Hearing Tests | 1 | 2003 | 14 | 0.220 |
Why?
|
| Steroids | 1 | 2004 | 203 | 0.210 |
Why?
|
| Prospective Studies | 13 | 2019 | 6028 | 0.210 |
Why?
|
| Palatine Tonsil | 3 | 2014 | 35 | 0.210 |
Why?
|
| Tongue | 1 | 2003 | 30 | 0.210 |
Why?
|
| Articulation Disorders | 1 | 2002 | 4 | 0.210 |
Why?
|
| Surgery, Oral | 1 | 2002 | 7 | 0.210 |
Why?
|
| Neck | 2 | 2020 | 138 | 0.210 |
Why?
|
| Lymphadenitis | 1 | 2023 | 26 | 0.210 |
Why?
|
| Tracheostomy | 2 | 2020 | 191 | 0.210 |
Why?
|
| Acetaminophen | 2 | 2020 | 91 | 0.210 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2023 | 60 | 0.200 |
Why?
|
| Pain Management | 2 | 2021 | 174 | 0.200 |
Why?
|
| Delphi Technique | 2 | 2021 | 200 | 0.200 |
Why?
|
| Maxillary Sinus | 3 | 2016 | 14 | 0.200 |
Why?
|
| Retrospective Studies | 10 | 2020 | 15979 | 0.200 |
Why?
|
| Treatment Outcome | 11 | 2022 | 12102 | 0.200 |
Why?
|
| Hearing Disorders | 1 | 2001 | 25 | 0.190 |
Why?
|
| Specialty Boards | 1 | 2021 | 21 | 0.190 |
Why?
|
| Mycetoma | 1 | 2001 | 3 | 0.190 |
Why?
|
| Otitis Externa | 1 | 2001 | 5 | 0.190 |
Why?
|
| Middle Ear Ventilation | 3 | 2009 | 29 | 0.190 |
Why?
|
| Lymphatic System | 1 | 2001 | 20 | 0.190 |
Why?
|
| Polysomnography | 2 | 2000 | 137 | 0.190 |
Why?
|
| Scedosporium | 1 | 2001 | 7 | 0.190 |
Why?
|
| Length of Stay | 4 | 2020 | 1284 | 0.190 |
Why?
|
| Jugular Veins | 1 | 2001 | 72 | 0.180 |
Why?
|
| Follow-Up Studies | 9 | 2015 | 5047 | 0.180 |
Why?
|
| Bevacizumab | 1 | 2021 | 63 | 0.180 |
Why?
|
| Codeine | 1 | 2000 | 24 | 0.180 |
Why?
|
| Aneurysm | 1 | 2001 | 88 | 0.180 |
Why?
|
| Adolescent | 13 | 2020 | 19086 | 0.180 |
Why?
|
| Vestibular Aqueduct | 1 | 2000 | 3 | 0.170 |
Why?
|
| Physicians, Women | 1 | 2020 | 46 | 0.170 |
Why?
|
| Head | 1 | 2020 | 102 | 0.170 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2003 | 312 | 0.170 |
Why?
|
| Clinical Competence | 3 | 2021 | 978 | 0.170 |
Why?
|
| Retropharyngeal Abscess | 1 | 1999 | 7 | 0.170 |
Why?
|
| Fatal Outcome | 3 | 2007 | 357 | 0.170 |
Why?
|
| Awards and Prizes | 1 | 2020 | 63 | 0.170 |
Why?
|
| Drug Administration Schedule | 2 | 2011 | 730 | 0.170 |
Why?
|
| Hearing Loss | 2 | 2011 | 131 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2020 | 711 | 0.170 |
Why?
|
| Sinusitis | 2 | 2017 | 117 | 0.160 |
Why?
|
| Professional Role | 1 | 2019 | 57 | 0.160 |
Why?
|
| Video Recording | 2 | 2019 | 181 | 0.160 |
Why?
|
| Lung | 1 | 2007 | 1469 | 0.160 |
Why?
|
| Injections, Intralesional | 3 | 2017 | 48 | 0.160 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 43 | 0.160 |
Why?
|
| Tonsillitis | 2 | 2014 | 13 | 0.160 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 477 | 0.160 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2019 | 18 | 0.160 |
Why?
|
| Audiovisual Aids | 1 | 2019 | 25 | 0.160 |
Why?
|
| Physician Assistants | 1 | 2019 | 59 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 208 | 0.160 |
Why?
|
| Vestibular Diseases | 1 | 2000 | 67 | 0.160 |
Why?
|
| Larynx | 3 | 2009 | 69 | 0.160 |
Why?
|
| Epiglottis | 1 | 1998 | 9 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1999 | 66 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2021 | 326 | 0.150 |
Why?
|
| Digestive System | 1 | 1998 | 59 | 0.150 |
Why?
|
| Laryngoscopy | 3 | 2010 | 149 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1999 | 75 | 0.150 |
Why?
|
| Prenatal Diagnosis | 2 | 2016 | 580 | 0.150 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 263 | 0.150 |
Why?
|
| Esophagus | 2 | 1998 | 213 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 258 | 0.150 |
Why?
|
| Respiratory System | 1 | 1998 | 95 | 0.150 |
Why?
|
| Histamine Antagonists | 1 | 2017 | 17 | 0.150 |
Why?
|
| Otolaryngologists | 1 | 2017 | 9 | 0.150 |
Why?
|
| California | 3 | 2004 | 128 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 1684 | 0.140 |
Why?
|
| Drinking Behavior | 1 | 1997 | 8 | 0.140 |
Why?
|
| Osteomalacia | 1 | 2017 | 7 | 0.140 |
Why?
|
| Giant Cell Tumors | 1 | 2017 | 5 | 0.140 |
Why?
|
| Haiti | 1 | 2016 | 10 | 0.140 |
Why?
|
| Maxillary Neoplasms | 1 | 2017 | 4 | 0.140 |
Why?
|
| Cleft Palate | 2 | 2009 | 140 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 278 | 0.140 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2017 | 16 | 0.140 |
Why?
|
| Rhinitis | 1 | 2017 | 38 | 0.140 |
Why?
|
| Foreign Bodies | 1 | 1998 | 104 | 0.140 |
Why?
|
| Cystic Fibrosis | 4 | 2002 | 257 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1998 | 224 | 0.140 |
Why?
|
| Pediatricians | 1 | 2017 | 65 | 0.140 |
Why?
|
| Ear, External | 1 | 1996 | 21 | 0.130 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2016 | 6 | 0.130 |
Why?
|
| Pepsin A | 1 | 1996 | 12 | 0.130 |
Why?
|
| Age Factors | 3 | 2013 | 2801 | 0.130 |
Why?
|
| Gastric Acid | 1 | 1996 | 50 | 0.130 |
Why?
|
| Surveys and Questionnaires | 6 | 2023 | 3662 | 0.130 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2002 | 45 | 0.130 |
Why?
|
| Acoustic Impedance Tests | 3 | 2010 | 7 | 0.130 |
Why?
|
| Burns, Chemical | 1 | 1996 | 29 | 0.130 |
Why?
|
| Acupuncture Therapy | 1 | 2015 | 11 | 0.120 |
Why?
|
| Hypoglossal Nerve Injuries | 1 | 1995 | 1 | 0.120 |
Why?
|
| Genetic Therapy | 4 | 2002 | 673 | 0.120 |
Why?
|
| Neck Injuries | 1 | 1995 | 22 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 2015 | 104 | 0.120 |
Why?
|
| Patient Selection | 2 | 2020 | 685 | 0.120 |
Why?
|
| Androstadienes | 1 | 2014 | 49 | 0.120 |
Why?
|
| Chondroma | 1 | 2014 | 6 | 0.120 |
Why?
|
| Wounds, Penetrating | 1 | 1995 | 139 | 0.120 |
Why?
|
| Adult | 12 | 2016 | 29035 | 0.110 |
Why?
|
| Ribs | 1 | 2014 | 44 | 0.110 |
Why?
|
| Double-Blind Method | 4 | 2015 | 1588 | 0.110 |
Why?
|
| Dilatation | 1 | 2013 | 68 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 234 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2017 | 2043 | 0.110 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2016 | 221 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 2397 | 0.110 |
Why?
|
| Neuromuscular Agents | 1 | 2013 | 67 | 0.110 |
Why?
|
| Parents | 1 | 2020 | 1023 | 0.110 |
Why?
|
| Gastroesophageal Reflux | 1 | 1996 | 289 | 0.100 |
Why?
|
| Wound Healing | 1 | 1996 | 452 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2011 | 74 | 0.100 |
Why?
|
| Risk Factors | 6 | 2011 | 10001 | 0.100 |
Why?
|
| Maxillary Sinusitis | 3 | 2002 | 3 | 0.090 |
Why?
|
| Hypertrophy | 2 | 2003 | 100 | 0.090 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2013 | 167 | 0.090 |
Why?
|
| Dependovirus | 3 | 2002 | 130 | 0.090 |
Why?
|
| Esophagoscopy | 1 | 2011 | 157 | 0.090 |
Why?
|
| Ear Diseases | 1 | 2010 | 18 | 0.090 |
Why?
|
| Bronchoscopy | 2 | 2009 | 157 | 0.090 |
Why?
|
| Propranolol | 1 | 2010 | 128 | 0.090 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2010 | 15 | 0.080 |
Why?
|
| Prognosis | 3 | 2008 | 4508 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 1998 | 1013 | 0.080 |
Why?
|
| Otitis Media with Effusion | 1 | 2009 | 18 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 2838 | 0.080 |
Why?
|
| Glottis | 1 | 2009 | 31 | 0.080 |
Why?
|
| Laryngostenosis | 1 | 2009 | 36 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 1259 | 0.080 |
Why?
|
| Hearing Loss, Conductive | 1 | 2008 | 13 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 234 | 0.080 |
Why?
|
| Hospitals, Pediatric | 3 | 2019 | 780 | 0.080 |
Why?
|
| Immunophenotyping | 1 | 2009 | 330 | 0.080 |
Why?
|
| Consensus | 2 | 2022 | 612 | 0.080 |
Why?
|
| Microsurgery | 1 | 2008 | 70 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1114 | 0.070 |
Why?
|
| Students | 1 | 2010 | 253 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 1240 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2016 | 906 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2007 | 3007 | 0.070 |
Why?
|
| Microscopy | 1 | 2007 | 118 | 0.070 |
Why?
|
| Ascites | 1 | 2007 | 87 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 1 | 2007 | 68 | 0.070 |
Why?
|
| Poverty | 1 | 2010 | 420 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1871 | 0.060 |
Why?
|
| Laser Therapy | 1 | 2008 | 246 | 0.060 |
Why?
|
| Bradycardia | 1 | 2006 | 59 | 0.060 |
Why?
|
| Multigene Family | 1 | 2006 | 298 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2016 | 3518 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2007 | 350 | 0.060 |
Why?
|
| Infant Welfare | 1 | 2004 | 27 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 1257 | 0.060 |
Why?
|
| Rabbits | 2 | 2014 | 696 | 0.060 |
Why?
|
| Child Welfare | 1 | 2004 | 66 | 0.060 |
Why?
|
| Aged | 2 | 2016 | 19068 | 0.060 |
Why?
|
| Adenoids | 1 | 2003 | 12 | 0.050 |
Why?
|
| Audiometry, Evoked Response | 1 | 2003 | 3 | 0.050 |
Why?
|
| Oral Surgical Procedures | 1 | 2003 | 14 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 1013 | 0.050 |
Why?
|
| Speech Intelligibility | 1 | 2002 | 4 | 0.050 |
Why?
|
| Speech Articulation Tests | 1 | 2002 | 8 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2023 | 36 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2004 | 272 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 8868 | 0.050 |
Why?
|
| Otoscopes | 1 | 2002 | 4 | 0.050 |
Why?
|
| Middle Aged | 3 | 2016 | 25976 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2009 | 111 | 0.050 |
Why?
|
| Tracheal Stenosis | 1 | 2022 | 31 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2017 | 671 | 0.050 |
Why?
|
| Patient Care | 1 | 2023 | 100 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2004 | 196 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1172 | 0.050 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 157 | 0.050 |
Why?
|
| Quality of Life | 2 | 2003 | 1931 | 0.050 |
Why?
|
| Hospital Volunteers | 1 | 2001 | 1 | 0.050 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 22 | 0.050 |
Why?
|
| Syndrome | 2 | 2006 | 1114 | 0.050 |
Why?
|
| Audiometry | 1 | 2001 | 21 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 3377 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 238 | 0.050 |
Why?
|
| Genetic Vectors | 3 | 2002 | 935 | 0.050 |
Why?
|
| Peru | 2 | 2011 | 45 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2001 | 93 | 0.050 |
Why?
|
| Mastoiditis | 1 | 2001 | 31 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 164 | 0.050 |
Why?
|
| Trachea | 1 | 2022 | 202 | 0.050 |
Why?
|
| Program Development | 1 | 2001 | 190 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 965 | 0.040 |
Why?
|
| Internationality | 1 | 2021 | 130 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 42 | 0.040 |
Why?
|
| Hydrocodone | 1 | 2020 | 35 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 294 | 0.040 |
Why?
|
| Pregnancy | 2 | 2016 | 7124 | 0.040 |
Why?
|
| HIV Infections | 1 | 2011 | 1868 | 0.040 |
Why?
|
| Canada | 1 | 2000 | 294 | 0.040 |
Why?
|
| Tracheotomy | 1 | 1999 | 35 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2001 | 230 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2001 | 449 | 0.040 |
Why?
|
| Airway Resistance | 1 | 1999 | 36 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 271 | 0.040 |
Why?
|
| Hospitalization | 2 | 1998 | 1733 | 0.040 |
Why?
|
| Acute Disease | 1 | 2002 | 1090 | 0.040 |
Why?
|
| Income | 1 | 2019 | 133 | 0.040 |
Why?
|
| Parvoviridae Infections | 1 | 1999 | 36 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 1102 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 1998 | 236 | 0.040 |
Why?
|
| Bronchography | 1 | 1998 | 4 | 0.040 |
Why?
|
| Data Collection | 1 | 2000 | 386 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2001 | 293 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 352 | 0.040 |
Why?
|
| Age of Onset | 1 | 2000 | 581 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 298 | 0.040 |
Why?
|
| Safety | 1 | 1999 | 217 | 0.040 |
Why?
|
| Patient Admission | 1 | 1999 | 184 | 0.040 |
Why?
|
| Incidence | 2 | 2009 | 3050 | 0.040 |
Why?
|
| Drainage | 1 | 1999 | 254 | 0.040 |
Why?
|
| Time Factors | 3 | 2003 | 6201 | 0.040 |
Why?
|
| Nasal Sprays | 1 | 2017 | 8 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 1999 | 209 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 1998 | 156 | 0.040 |
Why?
|
| Genu Valgum | 1 | 2017 | 3 | 0.040 |
Why?
|
| Rickets | 1 | 2017 | 9 | 0.040 |
Why?
|
| Oral Ulcer | 1 | 2017 | 4 | 0.040 |
Why?
|
| Hypophosphatemia | 1 | 2017 | 9 | 0.040 |
Why?
|
| Triamcinolone | 1 | 2017 | 14 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 1149 | 0.030 |
Why?
|
| Alopecia | 1 | 2017 | 36 | 0.030 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2017 | 30 | 0.030 |
Why?
|
| Ear Cartilage | 1 | 1996 | 2 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2016 | 10 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 55 | 0.030 |
Why?
|
| Calcitriol | 1 | 2017 | 80 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2019 | 264 | 0.030 |
Why?
|
| Vinblastine | 1 | 2016 | 46 | 0.030 |
Why?
|
| Nasal Septum | 1 | 1996 | 17 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2017 | 1167 | 0.030 |
Why?
|
| Mercaptopurine | 1 | 2016 | 71 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 2024 | 0.030 |
Why?
|
| Caustics | 1 | 1996 | 5 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 291 | 0.030 |
Why?
|
| Nose | 1 | 1996 | 92 | 0.030 |
Why?
|
| Prednisone | 1 | 2016 | 273 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 154 | 0.030 |
Why?
|
| Anesthesia | 1 | 1998 | 212 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2021 | 624 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1999 | 547 | 0.030 |
Why?
|
| Hypoglossal Nerve | 1 | 1995 | 9 | 0.030 |
Why?
|
| Paralysis | 1 | 1995 | 35 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1105 | 0.030 |
Why?
|
| Fluticasone | 1 | 2014 | 15 | 0.030 |
Why?
|
| Homicide | 1 | 1995 | 30 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 4268 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 16 | 0.030 |
Why?
|
| Surgery, Plastic | 1 | 1996 | 110 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 2405 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1597 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 516 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 722 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 680 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 671 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 645 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 280 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2851 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 359 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1996 | 1387 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2000 | 3332 | 0.020 |
Why?
|
| Otoscopy | 1 | 2010 | 7 | 0.020 |
Why?
|
| Otitis Media, Suppurative | 1 | 2010 | 4 | 0.020 |
Why?
|
| Audiology | 1 | 2009 | 5 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2009 | 22 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 24 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 104 | 0.020 |
Why?
|
| Gene Transfer Techniques | 2 | 2002 | 355 | 0.020 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2008 | 9 | 0.020 |
Why?
|
| Connexin 26 | 1 | 2006 | 13 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 1245 | 0.020 |
Why?
|
| Anion Transport Proteins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Connexins | 1 | 2006 | 59 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 141 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 239 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 793 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 33740 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 499 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2002 | 7 | 0.010 |
Why?
|
| Nasal Lavage Fluid | 1 | 2002 | 14 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2002 | 130 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2002 | 183 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1431 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2002 | 170 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 211 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2000 | 36 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 4708 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 348 | 0.010 |
Why?
|
| Maxillofacial Development | 1 | 1996 | 2 | 0.010 |
Why?
|
| Nasal Obstruction | 1 | 1996 | 14 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1294 | 0.010 |
Why?
|
| Anthropometry | 1 | 1996 | 197 | 0.010 |
Why?
|
| Recurrence | 1 | 1999 | 1420 | 0.010 |
Why?
|
| Models, Biological | 1 | 1999 | 1442 | 0.010 |
Why?
|